Atlas FDA

CAPI 3 HEMOGLOBIN(E)

FDA 510(k) clearance K180762 · decided 2018-12-14

Clearance details

K-number
K180762
Device name
CAPI 3 HEMOGLOBIN(E)
Applicant
Sebia
Decision
Substantially Equivalent
Date received
2018-03-23
Decision date
2018-12-14
Days to decision
266 days
Clearance type
Traditional
Product code
GKA
Device class
2
Regulation number
864.7415
Medical specialty
Hematology
Advisory committee
Hematology
Location
Norcross, GA, US
Third-party review
No
Expedited review
No

+ Add to Predicate Builder ◉ Watch Sebia

Need this as data, not a web page?

Query all 176,000+ clearances through the Atlas FDA API, or subscribe to weekly change alerts. Self-serve from $29/mo.

Similar devices under this product code

Devices cleared under the same product code - the starting set for predicate research.

RecordFirmDate
CAPI 3 NEONAT Hb, CAPILLARYS 3 DBS Instrument (K232027)Sebia2024-04-04
Premier Resolution System (K222635)Trinity Biotech (Primus Corporation, Dba Trinity Biotech)2023-08-04
V8 Nexus Hemoglobin Ultrascreen, V8 AFSA2 Hemo Control (K192931)Helena Laboratories, Corp.2022-04-19
Hemoglobin Variants System on Newborn Hemoglobin System with GDM and HbReview Software (K171664)Bio-Rad Laboratories, Inc.2017-09-13
CAPILLARYS HEMOGLOBIN, CAPILLARYS FLEX PIERCING SYSTEM (K112550)Sebia2012-05-25
SEBIA CAPILLARYS HEMOGLOBIN(E) WITH CAPILLARYS 2 (K112491)Sebia2012-05-24
CAPILLARYS NEONAT HB (PN 2006) (K091283)Sebia2010-02-22
MINICAP HEMOGLOBIN(E) KIT, MODEL 2207, 2227 (K082227)Sebia2009-03-26
VARIANT NBS SICKLE CELL PROGRAM REAGENT KIT, VARIANT NBS NEWBORN SCREENING SYSTEM AND VARIANT NBS WORKSTATION WITH (K080911)Bio-Rad Laboratories Inc., Clinical Systems Divisi2008-05-02
CAPILLARY'S HEMOGLOBIN(E) (PN 2007) (K052291)Sebia2006-06-27
RESOLVE HEMOGLOBIN KIT, JB-2 STAINING SYSTEM, MODELS FR-9120, FR-9400, FR-9360, FR-9367 (K050709)Wallac OY2006-03-08
BIO-RAD VARIANT NBS SICKLE CELL PROGRAM (K051072)Bio-Rad Laboratories, Inc.2005-05-12

Recalls involving this device

No recalls on record reference this clearance.